Clinical Trials Directory

Trials / Unknown

UnknownNCT02008812

Ad Sensor-based Real-time Diagnosis of Adenovirus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

To develop a real-time diagnostic technique with Ad sensor for Adenovirus detection, the investigators conduct a prospective clinical study. In comparison with results from direct sequencing of Adenovirus, the investigators evaluate the performance of Ad sensor , including reproducibility, sensitivity, specificity, and cross-reaction. The potential factors which may interfere with the results would be investigated. With such technique, the investigators hope to make early diagnosis and give Adenovirus patients early treatment to reduce the complications and case-fatality rate.

Detailed description

1. Sample acquirement: At National Taiwan University Hospital in Taiwan, we will enroll patients who have Adenovirus infection . We will take three throat swabs for each patient: one for viral isolation, one for RT-PCR and the last for the Ad sensor - based real-time diagnosis. 2. Ad sensor diagnosis: Ad sensor (structural chip-based optosensing virus probing system), which is for the rapid and sensitive detection of viral antigen in medical samples, will be used for analyzing the interaction kinetics between anti-Adenovirus and its Adenovirus antigen present in patients'and normal samples. 3. Gold standard: viral isolation and RT-PCR

Conditions

Interventions

TypeNameDescription
DEVICEAd sensorAd sensor, which was developed for the rapid and sensitive detection of viral antigen in medical samples, will be used for analyzing the interaction kinetics between anti-Adenovirus and its Adenovirus antigen present in patients and normal samples. The system incorporates the use of chip formats. In antibody probing, antibodies are bound as a suitable probe, which specifically and selectively binds targeted molecules (virus antigen) in the test specimens.

Timeline

Start date
2011-08-01
Primary completion
2015-08-01
Completion
2015-12-01
First posted
2013-12-11
Last updated
2013-12-16

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02008812. Inclusion in this directory is not an endorsement.